MedPath

Does offering a hybrid cardiac rehabilitation programme increase uptake and adherence compared to in-person programmes?

Not Applicable
Conditions
Cardiac rehabilitation in people with cardiovascular disease
Circulatory System
Registration Number
ISRCTN12527081
Lead Sponsor
niversity of Birmingham
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
540
Inclusion Criteria

Work package 1 (NACR data):
Invited to cardiac rehabilitation. If there are sufficient numbers the sample will be limited to people who have acute coronary syndrome. This will make the sample homogeneous in terms of the index condition.

Work package 2 (qualitative):
1. Staff involved in the delivery or management of a cardiac rehabilitation service offering a hybrid programme using
Active_me for the remote part of the programme
2. Patients who were offered and/or engaged with a hybrid cardiac rehab programme using Active+me

Exclusion Criteria

Work package 1 (NACR data):
Does not meet the inclusion criteria

Work package 2 (qualitative):
1. Staff not involved in the delivery or management of a cardiac rehabilitation service offering a hybrid programme using Active_me for the remote part of the programme
2. Patients who were not offered the hybrid cardiac rehab programme using Active+me

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ptake of cardiac rehabilitation, defined as attending at least one CR session, either in-person or remotely, recorded on the NACR database within 6 months of referral. A session will be defined in accordance with version 1.2 of the BACPR/NACR definition (June 2020).
Secondary Outcome Measures
NameTimeMethod
1. Adherence to cardiac rehabilitation will be measured as at least 50% of planned cardiac rehabilitation sessions attended and a completion date recorded within approx. 6 months after programme start<br>2. Health-related quality of life measured by the Dartmouth CO-OP charts measured at programme start and end (approx. 3 months) <br>3. Anxiety and depression scores measured by the Hospital Anxiety and Depression Scale, the Generalised Anxiety Disorder Assessment (GAD-7) and Patient Health Questionnaire (PHQ-9) at programme start and end (approx. 3 months)<br>4. Fitness measured by incremental shuttle walk test or 6-minute walk test at programme start and end (approx. 3 months) <br>5. Smoking cessation measured using self report at programme start and end (approx. 3 months) <br>6. Self-report of 150 min physical activity/week at programme end (approx. 3 months)
© Copyright 2025. All Rights Reserved by MedPath